Identifying Progression

Regular monitoring of your patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) is essential to detect progression and to determine the need for a change in therapy.¹The progression brochure and slide deck are easy to read guides on how to understand and identify disease progression in patients with GEP-NETs.

Identifying and assessing progression

Progression Brochure

Referring a patient for PRRT?

If you are referring your patient for PRRT, it is important you consider the following questions:

Do you have the patient’s full medical history?
What are the patient’s haematology results?
What are the patient’s tumour markers?
What is their current cardiac status?
What is the evidence for progression?
Do you have the patient’s background information?

To help keep a record of this information and aid the decision-making process, click below to download the Patient Referral Form.

Preview image of the patient referral form

Reference

1. Merino-Casabiel X, et al. Clin Transl Oncol. 2018;20:1522–8.

AAA-Lu177-UK-2148 | October 2023

Disease Background

Find easy-to-digest materials, which will provide you with an overview of NETs, covering incidence and presentation through to diagnosis and treatment.

AAA-Lu177-UK-2147 | October 2023